11 min listen
E9: Rituximab in Myositis - The RIM Trial
E9: Rituximab in Myositis - The RIM Trial
ratings:
Length:
17 minutes
Released:
Feb 21, 2018
Format:
Podcast episode
Description
This week we'll discuss a randomized controlled-ish trial, the RIM study. It pits rituximab against placebo as well as... rituximab? We'll talk about how their design convincingly demonstrated that ritixan does not have a benefit over placebo for 8 weeks, but may or may not work after that. Find the trial itself here.
Released:
Feb 21, 2018
Format:
Podcast episode
Titles in the series (87)
E17: Steroids and the Risk of Scleroderma Renal Crisis: Short but impactful paper this week on the association between steroids and scleroderma renal crisis. Find the original paper here. by The Evidence Based Rheumatology Podcast